Enlivex Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Enlivex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enlivex Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enlivex Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.2k | 4.0k | 1.04 |
| 2025-03-31 | $16 | 16 | 1.00 |
| 2024-12-31 | $19 | 16 | 1.19 |
| 2024-09-30 | $5.4k | 3.2k | 1.69 |
| 2024-06-30 | $23 | 16 | 1.44 |
| 2024-03-31 | $12k | 3.1k | 3.79 |
| 2023-12-31 | $9.9k | 3.7k | 2.70 |
| 2023-09-30 | $1.1k | 690 | 1.58 |
| 2023-06-30 | $47k | 18k | 2.63 |
| 2023-03-31 | $115k | 32k | 3.64 |
| 2022-12-31 | $132k | 33k | 3.94 |
| 2022-09-30 | $159k | 32k | 5.00 |
| 2022-06-30 | $83k | 18k | 4.49 |
| 2022-03-31 | $96k | 18k | 5.42 |
| 2021-12-31 | $135k | 22k | 6.25 |
| 2021-09-30 | $144k | 16k | 9.33 |
| 2021-06-30 | $125k | 13k | 9.33 |
| 2021-03-31 | $120k | 11k | 11.07 |
| 2020-12-31 | $189k | 22k | 8.44 |
| 2020-09-30 | $61k | 10k | 5.96 |
| 2020-06-30 | $2.0k | 344 | 5.81 |
| 2019-12-31 | $24k | 2.9k | 8.35 |
| 2019-09-30 | $85k | 3.2k | 26.72 |
| 2019-06-30 | $33k | 1.5k | 21.43 |